Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 20 horas · Los investigadores del centro de investigación Breast Cancer Now Toby Robins ... una biopsia líquida que permite detectar la aparición de tumores de mama/Archivo Johns Hopkins Kimmel Cancer ...

  2. Hace 4 días · In this phase 1 trial, treatment of patients with ER+HER2− metastatic breast cancer with a selective catalytic inhibitor of the lysine acetyltransferase KAT6 shows a manageable safety profile ...

  3. Hace 2 días · UNIQUE VARIANTS—AND RISKS . T hough Black and white women have similar breast cancer incidence rates, Black women are more than 40% more likely to die from the disease. They develop more aggressive breast cancer tumors and are diagnosed younger. Epidemiologists have associated environmental factors such as neighborhood deprivation, exposure to pollutants, and racism with more aggressive ...

  4. Hace 2 días · Department of Neurology, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. ... To further investigate the potential use of EVs as a source of breast cancer biomarkers, we have discussed the use of these proteins as predictive marker candidates.

  5. Hace 6 días · A Johns Hopkins University-led research team has designed a method to generate enormous datasets of artificial, automatically annotated liver tumors on CT scans, enabling artificial intelligence models to be trained to accurately identify real tumors without human help.

  6. 9 de may. de 2024 · Beating breast cancer in Africa. May 9, 2024. In the United States, 90% of patients diagnosed with stage I breast cancer will survive at least five years beyond diagnosis. But in other parts of the world, survival rates are alarmingly lower; for example, in Uganda, about half of all breast cancer patients die within the same time frame.

  7. 21 de may. de 2024 · Studies show the drug shrinks tumors, reduces cancer spread and increases survival in animals with cancers of the skin, colon, blood and brain, as well as certain treatment-resistant breast cancers.